PAR — Paradigm Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall Cap

Annual balance sheet for Paradigm Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	R2023 June 30th	R2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	—	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	39.7	56.4	17.9	16.8	15.4
Net Total Accounts Receivable
Net Total Receivables	6.72	7.87	6.07	6.37	13.1
Prepaid Expenses
Total Current Assets	47.2	64.8	25.2	24.1	29.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.571	0.336	0.19	0.03	0.499
Net Intangible Assets
Other Long Term Assets
Total Assets	50.7	68.1	28.4	24.6	30.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.83	13	3.36	3.23	26.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	8.38	13.4	3.58	3.39	27.1
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	42.3	54.7	24.8	21.2	3.47
Total Liabilities & Shareholders' Equity	50.7	68.1	28.4	24.6	30.6
Total Common Shares Outstanding